Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology
Published in: European Archives of Oto-Rhino-Laryngology 10/2005

01-10-2005 | Miscellaneous

Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire

Authors: Ilias Karapantzos, Nikolaos Tsimpiris, Dimitrios G. Goulis, Helen Van Hoecke, Paul Van Cauwenberge, Vasilis Danielides

Published in: European Archives of Oto-Rhino-Laryngology | Issue 10/2005

Login to get access

Abstract

The purpose of this study was to describe the results of Nd:YAG laser application in hereditary hemorrhagic telangiectasia (HHT) patients and to measure the Health-Related Quality of Life (HR-QoL) in patients with HHT before and after Nd:YAG laser application in a prospective, clinical trial at a university hospital. Twenty-seven consecutive patients with HHT and mild to moderate degrees of epistaxis were followed-up for 2 years after Nd:YAG laser treatments. Recurrence of epistaxis after Nd:YAG laser application and measurement of HR-QoL using the International Quality of Life Assessment questionnaire, version 1.1 (IQOLA 1.1), was found. Eight patients (30%) received only one Nd:YAG laser treatment, 15 (56%) had a recurrence and received a second treatment and 4 (14%) had two recurrences and received three Nd:YAG laser treatments. HR-QoL was improved 2 years after the first Nd:YAG laser application in both its Physical Health Dimension (47.5±2.9 vs. 38.1±2.3 before treatment, P <0.05) and Mental Health Dimension (45.1±2.7 vs. 39.6±2.4 before treatment, P <0.05). Although no curative treatment for HHT exists, Nd:YAG laser treatment seems to constitute a simple and efficient method of epistaxis control, resulting in a significant improvement in quality of life.
Literature
1.
Rendu M (1896) Epistaxis repetees chez un sujet porteur de petits angiomescutanes et mugueux. Bull Mem Soc Med Hop Paris 13:731–733
2.
Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Johns Hopkins Hops Bull 12:333–337
3.
Mei-Zahav M (2003) Osler-Weber-Rendu: a life-threatening disease in adults and children. Harefuah 142:852–856
4.
Marchuk D (1998) Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr Opin Hematol 5:332–338
5.
Shah R, Dhingra J, Shapshay S (2002) Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 112:767–773
6.
Haitjema T, Westermann C, Overtoom T, Timmer R, Disch F, Mauser H, Lammers J (1996) Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 156:714–719CrossRefPubMed
7.
Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76:495–501
8.
Shovlin C, Guttmacher A, Buscarini E, Faughnan M, Hyland R, Westermann C, Kjeldsen A, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67CrossRefPubMed
9.
Byahatti S, Rebeiz E, Shapshay S (1997) Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know. Am J Rhinol 11:55–62
10.
Lund V, Howard D (1999) A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319–322
11.
Weissman J, Jungreis C, Johnson J (1995) Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia. Am J Otolaryngol 16:138–140
12.
Pizzi G, Turcato G, Polico R, Busetto M, Antonello M, Princivalli M (1995) Brachytherapy of epistaxis in Rendu-Osler disease. Indications, technic, results. Radiol Med (Torino) 89:861–864
13.
Rebeiz E, Bryan D, Ehrlichman R, Shapshay S (1995) Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease. Ann Plast Surg 35:208–213
14.
Lennox P, Harries M, Lund V, Howard D (1997) A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol 111:34–37
15.
Ducic Y, Brownrigg P, Laughlin S (1995) Treatment of haemorrhagic telangiectasia with the flashlamp-pulsed dye laser. J Otolaryngol 24:299–302
16.
Vickery C, Kuhn F (1996) Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 89:78–80
17.
Kardos T, Holt T, Ferguson M (1989) Histological evaluation of the effect of a miniature carbon dioxide laser on oral mucosa. Int J Oral Maxillofac Surg 18:117–120
18.
Shapshay S, Rebeiz E, Bohigian R, Hybels R (1990) Benign lesions of the larynx: should the laser be used? Laryngoscope 100:953–957
19.
Bergler W, Gotte K, Riedel F, Back W, Hormann K (1998) Argon plasma coagulation in treatment of hereditary telangiectasia of the nasal mucosa. HNO 46:228–232
20.
Bergler W, Sadick H, Gotte K, Riedel F, Hormann K (2002) Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 111:222–228
Metadata
Title
Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire
Authors
Ilias Karapantzos
Nikolaos Tsimpiris
Dimitrios G. Goulis
Helen Van Hoecke
Paul Van Cauwenberge
Vasilis Danielides
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 10/2005
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-004-0911-0

Other articles of this Issue 10/2005

European Archives of Oto-Rhino-Laryngology 10/2005 Go to the issue

Otology

Effects of the acute exposure to the electromagnetic field of mobile phones on human auditory brainstem responses

Otology

Smooth muscle choristoma of the internal auditory meatus

Head and Neck Oncology

Angiofibroma: an outcome review of conventional surgical approaches

Phoniatrics

Bipolar radiofrequency-induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases

Otology

The chondroid syringoma: report of a case arising from the external auditory canal

Otology

Cochlear implantation and management of chronic suppurative otitis media: single stage procedure?